Archived Medical News Stories

RSSArchived Pharmaceutical News Stories - June 2006

Date Title Comments Rating
2006-06-29 FDA grants accelerated approval for Sprycel (dasatinib) 0 None
2006-06-28 Brits first to get new obesity drug 0 None
2006-06-27 First-in-class biologics poised to drive malignant melanoma drug market 0 None
2006-06-27 FDA gives tentative approval for generic pediatric AIDS drug 0 None
2006-06-27 FDA approves Exelon to treat dementia of Parkinson's disease 0 None
2006-06-27 More problems for Merck over Vioxx 0 None
2006-06-27 Affymax and Takeda announce agreement for commercialization of Hematide for anemia 0 None
2006-06-26 FDA approves Prezista (darunavir) 0 None
2006-06-22 Experimental drug helps you age gracefully 0 None
2006-06-19 FDA warns of possible risks to children using Triaminic Vapor Patch 0 None
2006-06-18 First drug treatment for late-stage cervical cancer approved 0 None
2006-06-18 Doctors put their foot down over drug advertising 0 None
2006-06-14 New drug will treat those winter blues 0 None
2006-06-13 FDA approves Wellbutrin X for treatment of seasonal depression 0 None
2006-06-12 FDA approves cervical cancer vaccine 0 None
2006-06-12 FDA cracks down on fake drugs 0 None
2006-06-09 How cow warts, clergy sex surveys moved along cervical cancer vaccine 0 None
2006-06-09 New era in cancer prevention 0 None
2006-06-09 FDA approves Gardasil as a treatment for cervical cancer 0 None
2006-06-08 Markey Cancer Center receives approval to test cancer drug DB-67 0 None
2006-06-08 NHS could save 2 billion pounds by switching to generic cholesterol lowering drugs 0 None
2006-06-08 FDA approval of Gardasil to prevent cervical cancer 0 None
2006-06-08 Reovirus could be used to treat many forms of advanced cancer 0 None
2006-06-08 Europe gives approval for children to get Prozac 0 None
2006-06-07 Glivec the best news yet for cancer victims 0 None
2006-06-06 MS sufferers relieved as drug Tysabri goes back on the market 0 None
2006-06-05 FDA approves resumed marketing of Tysabri 0 None
2006-06-05 HHS awards BioShield contract heptavalent botulism antitoxin 0 None
2006-06-04 New EU rules mean medicines will be developed just for children 0 None


29 posts
0 raters